GlassScriptPhysician profile
Mary A Allen
NPI 1164726915
$455.86
in general payments reported to CMS, 2019-2025
9 companies · $22.32 in 2025
The $22.32 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.01 · 2023: $255 · 2024: $166 · 2025: $22.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioxcel Therapeutics, INC. | $90.26 | 2023 | Igalmi |
| Organogenesis INC. | $83.04 | 2023-2024 | Puraply |
| Philips North America LLC | $80.72 | 2023 | |
| Tactile Systems Technology INC | $77.99 | 2024 | Flexitouch Plus, Entre Plus |
| Hydrofera LLC | $33.03 | 2023 | Hydrofera Blue |
| Medtronic, INC. | $32.88 | 2024 | Venaseal |
| Smith+Nephew, INC. | $22.61 | 2023 | Collagenase Santyl |
| Neurocrine Biosciences, INC. | $22.32 | 2025 | |
| Hollister Incorporated | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.